Brevibacterium casei catheter-related bloodstream infection in an immunocompromised patient with multiorgan failure in Dubai hospital, UAE.
Abstract
Brevibacterium casei, historically regarded as a harmless skin commensal, is increasingly recognized as an opportunistic pathogen in immunocompromised individuals. Catheter-Related Bloodstream Infections (CRBSIs) due to B. casei remain rare but are clinically significant, particularly among patients with multiple comorbidities and indwelling vascular devices. We report a CRBSI caused by B. casei in a 69-year-old male with ischemic heart disease, chronic obstructive pulmonary disease and acute kidney injury. The diagnosis was established through blood cultures from both a dialysis catheter and a peripheral vein. The patient showed clinical improvement following catheter removal and a combination of Piperacillin-Tazobactam with Levofloxacin.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.